BIOTECH · Moonwalk raises $70M for a muscle-sparing fat drug
The Bay Area biotech's new injection aims to cut fat while keeping muscle, unlike today's popular GLP-1 weight-loss drugs.
@thedailyfathom.bsky.socialExplore
@thedailyfathom.bsky.social
@thedailyfathom.bsky.socialBIOTECH · Moonwalk raises $70M for a muscle-sparing fat drug
The Bay Area biotech's new injection aims to cut fat while keeping muscle, unlike today's popular GLP-1 weight-loss drugs.